KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Total Liabilities (2016 - 2026)

Medtronic (MDT) has disclosed Total Liabilities for 14 consecutive years, with $42.3 billion as the latest value for Q1 2026.

  • Quarterly Total Liabilities rose 4.78% to $42.3 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $42.3 billion through Jan 2026, up 4.78% year-over-year, with the annual reading at $43.4 billion for FY2025, 9.76% up from the prior year.
  • Total Liabilities hit $42.3 billion in Q1 2026 for Medtronic, roughly flat from $42.5 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $43.4 billion in Q2 2025 to a low of $37.1 billion in Q3 2022.
  • Historically, Total Liabilities has averaged $40.5 billion across 5 years, with a median of $40.4 billion in 2025.
  • Biggest five-year swings in Total Liabilities: dropped 15.65% in 2022 and later grew 9.76% in 2025.
  • Year by year, Total Liabilities stood at $41.2 billion in 2022, then fell by 6.66% to $38.4 billion in 2023, then increased by 7.51% to $41.3 billion in 2024, then grew by 2.81% to $42.5 billion in 2025, then dropped by 0.47% to $42.3 billion in 2026.
  • Business Quant data shows Total Liabilities for MDT at $42.3 billion in Q1 2026, $42.5 billion in Q4 2025, and $42.8 billion in Q3 2025.